1. Short title This Act may be cited as the PHEMCE Advisory Committee Act of 2023 . 2. Public Health Emergency Medical Countermeasures Enterprise (a) Members Section 2811–1(b) of the Public Health Service Act (42 U.S.C. 30hh–10a(b)) is amended by striking paragraph (11) and inserting the following: (11) The Director of the Biomedical Advanced Research and Development Authority. (12) The Director of the Strategic National Stockpile. (13) Representatives of any other Federal agency, which may include the Director of the National Institute of Allergy and Infectious Diseases and the Director of the Office of Public Health Preparedness and Response, as the Secretary determines appropriate. . (b) Functions Section 2811–1(c)(2) of the Public Health Service Act (42 U.S.C. 30hh–10a(c)(2)) is amended to read as follows: (2) Input In carrying out this section, the PHEMCE shall solicit and consider input from— (A) the PHEMCE Advisory Committee maintained under subsection (d), as appropriate; and (B) State, local, Tribal, and territorial public health departments or officials, as appropriate. . (c) Advisory committee Section 2811–1 of the Public Health Service Act ( 42 U.S.C. 30hh–10a ) is amended by adding at the end the following: (d) PHEMCE Advisory Committee (1) Establishment The Secretary shall— (A) establish and maintain an advisory committee to be known as the PHEMCE Advisory Committee (in this subsection referred to as the Advisory Committee ) to seek input and ensure communication and transparency in the functions of the PHEMCE; and (B) seek input from and consult with external partners with divergent threat portfolios, including chemical, biological, radiological, or nuclear agents and emerging infectious diseases, to ensure the right combination of threat-specific expertise on PHEMCE functions under subsection (c)(1) and to ensure appropriate capability and capacity to maintain overall readiness. (2) Duties The Advisory Committee shall— (A) provide advice to the PHEMCE in carrying out its functions